XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
 Latest Research
 Cancer
  Breast
  Skin
  Blood
  Prostate
  Liver
  Colon
  Thyroid
  Endometrial
  Brain
   Glioblastoma Multiforme
   Medulloblastoma
  Therapy
  Risk Factors
  Esophageal
  Bladder
  Lung
  Rectal Cancer
  Pancreatic Cancer
  Bone Cancer
  Cervical Cancer
  Testicular Cancer
  Gastric Cancer
  Ovarian Cancer
  Nerve Tissue
  Renal Cell Carcinoma
 Psychiatry
 Genetics
 Surgery
 Aging
 Ophthalmology
 Gynaecology
 Neurosciences
 Pharmacology
 Cardiology
 Obstetrics
 Infectious Diseases
 Respiratory Medicine
 Pathology
 Endocrinology
 Immunology
 Nephrology
 Gastroenterology
 Biotechnology
 Radiology
 Dermatology
 Microbiology
 Haematology
 Dental
 ENT
 Environment
 Embryology
 Orthopedics
 Metabolism
 Anaethesia
 Paediatrics
 Public Health
 Urology
 Musculoskeletal
 Clinical Trials
 Physiology
 Biochemistry
 Cytology
 Traumatology
 Rheumatology
 
 Medical News
 Health
 Opinion
 Healthcare
 Professionals
 Launch
 Awards & Prizes
 
 Careers
 Medical
 Nursing
 Dental
 
 Special Topics
 Euthanasia
 Ethics
 Evolution
 Odd Medical News
 Feature
 
 World News
 Tsunami
 Epidemics
 Climate
 Business
 
 India
Search

Last Updated: Nov 18, 2006 - 12:32:53 PM

Brain Channel
subscribe to Brain newsletter

Latest Research : Cancer : Brain

   DISCUSS   |   EMAIL   |   PRINT
Pituitary Gland Tumors Are Often Misdiagnosed
May 1, 2005 - 9:04:00 PM, Reviewed by: Dr.

"Conditions such as osteoporosis, sexual dysfunction, depression, infertility, or growth disorders can be the result of abnormalities in the pituitary or "master" gland at the base of the brain. Many times this association is overlooked"

 
A recent study found that tumors of the pituitary gland are more common than many health care professionals realize, with national prevalence rates averaging 16.7 percent.

To neurosurgeon Dr. Gail Rosseau, this isn't surprising.

Rosseau, who treats patients with a variety of neurological conditions at Rush University Medical Center and the Chicago Institute of Neurosurgery and Neuroresearch (CINN), says that pituitary tumors are often misdiagnosed because of the confusing array of symptoms they present.

"Conditions such as osteoporosis, sexual dysfunction, depression, infertility, or growth disorders can be the result of abnormalities in the pituitary or "master" gland at the base of the brain. Many times this association is overlooked," Rosseau said.

"These types of tumors are generally not malignant, but they have many different and highly variable ways of making their presence known, "she said. "If misdiagnosed or untreated, they may progress, causing blindness, heart disease or in the worst cases, premature death."

Because the disease is complex, Rosseau saw the need for a patient education association in the Chicagoland area. The Greater Chicago Pituitary Education Association was founded in late 2004 and is underwritten by a grant from The CINN Foundation. Each quarterly meeting of the Association provides an educational presentation from a member of the Chicago medical community involved in the treatment of pituitary disease. The Association aims to include physician speakers ranging from endocrinologists, to neurosurgeons, to ear, nose and throat specialists and bridge institutional alliances.

The next meeting will take place at 6:30 pm on Tuesday, May 3 at The Neurologic & Orthopedic Institute of Chicago, 4501 N. Winchester, ground level.

Many patients are concerned about treatments and surgery because of the location and function of the pituitary. The pituitary is a small, pea-sized gland located at the base of the brain that functions as "The Master Gland." It releases stimulating hormones that signal the thyroid gland, adrenal glands, ovaries and testes, directing them to produce their respective hormones. These hormones have dramatic effects on metabolism, blood pressure, sexuality, reproduction, and other vital body functions. In addition, the pituitary gland produces growth hormone for normal development of height and prolactin for milk production.

CINN psychologist Dino Kostas said pituitary tumor patients have unique concerns, such as loss of vision, that require a different approach. He emphasized that an educational seminar is a great way to allay patient fears while allowing patients to ask questions of anyone on the treatment team.

"Most patients contemplating surgery have fears and concerns about the surgery, but with our patients, we see a heightened level of anxiety about the potential loss of vision because the pituitary gland is so close to the optic nerve," Kostas said. "Frequently, we talk to many patients who are also fearful that they will have decreased libido or become infertile."

Treatment depends on the type of pituitary tumor, the extent to which it has invaded the brain, as well as the patient's age and general health. Treatment is most effective when diagnosis is early, and it typically involves surgery, radiosurgery, and/or drug therapy, Rosseau said.

Ear, nose and throat surgeon Dr. Steven Becker, said that he is able to calm many anxious patients because surgical techniques have vastly improved in the last decade and recovery times are typically one month, down from more than two months previously. Becker has performed approximately 600 of these surgeries.

"As recently as 10 years ago, surgeons would use a craniotomy, which requires an incision under the lip and a full elevation of half the facial tissues to access the nasal interior," he said. "Now, we use an endoscopically assisted approach to access the pituitary gland during the two and half hour surgery. This approach allows surgeons to go up the nasal cavity in a minimally invasive manner," Becker said.

He stressed that surgical candidates are typically those with a past history of sinusitis, or nasal trauma. Becker said that patients who attend the educational forum tend to make for better patients because they ask good questions and the forum helps lessen the anxiety they feel.
 

- Rush University Medical Center and the Chicago Institute of Neurosurgery and Neuroresearch (CINN)
 

www.rush.edu

 
Subscribe to Brain Newsletter
E-mail Address:

 

For more information about The Greater Chicago Pituitary Education Association, call 773.250.0484.

Rush University Medical Center includes the 729-bed Presbyterian-St. Luke's Hospital; 79-bed Johnston R. Bowman Health Center; Rush University (Rush Medical College, College of Nursing, College of Health Sciences and the Graduate College).

The CINN Foundation, a non-profit organization founded three years ago by Chicago neurosurgeon, Leonard J. Cerullo, M.D, underwrites the educational meeting for pituitary patients. The CINN Foundation is dedicated to improving the lives of individuals with neurologic disorders through basic and clinical research, education and community outreach. The Foundation supports researchers and educators focused on advancing the treatment of patients suffering from brain tumors, stroke, spinal cord injury and back disorders, epilepsy, and Parkinson's disease.

The Chicago Institute of Neurosurgery and Neuroresearch is one of the nation's leading organizations for the diagnosis, treatment and rehabilitation of people with brain and spine disorders. Originally founded in 1987, CINN is the Midwest's largest team of neurosurgeons known for their pioneering treatments in minimally invasive techniques. Through a network of eight hospitals spanning two states, CINN treats more patients with brain tumors and spine disorders than any other physician group in Illinois.

The Neurologic & Orthopedic Institute of Chicago is the country's first freestanding acute care hospital dedicated exclusively to neuroscience and orthopedic services. It utilizes breakthrough technology and minimally invasive techniques as well as advanced procedures for neurosurgery, orthopedics, pain management, neuro-oncology, sports medicine, and rehabilitation.


Related Brain News

Regulatory Approval for New Cotara(R) Brain Cancer Clinical Trial
Lead exposure linked with brain cancer
Synthetic scorpion venom delivers radioactive iodine to malignant gliomas
Chromosomal Testing Can Determine Brain Tumor Therapy
Motexafin gadolinium extends cognitive function in patients with brain metastases
New vaccine to fight glioblastoma multiforme developed
New mouse model that closely mimics human medulloblastoma
Immune response protects against brain tumor development
Long mobile use could cause brain tumours - New Study
Donepezil helps cognitive function in brain tumor patients after radiation


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us